Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials.

Nature Reviews. Drug Discovery
E Elizabeth PattonDavid M Langenau

Abstract

Numerous drug treatments that have recently entered the clinic or clinical trials have their genesis in zebrafish. Zebrafish are well established for their contribution to developmental biology and have now emerged as a powerful preclinical model for human disease, as their disease characteristics, aetiology and progression, and molecular mechanisms are clinically relevant and highly conserved. Zebrafish respond to small molecules and drug treatments at physiologically relevant dose ranges and, when combined with cell-specific or tissue-specific reporters and gene editing technologies, drug activity can be studied at single-cell resolution within the complexity of a whole animal, across tissues and over an extended timescale. These features enable high-throughput and high-content phenotypic drug screening, repurposing of available drugs for personalized and compassionate use, and even the development of new drug classes. Often, drugs and drug leads explored in zebrafish have an inter-organ mechanism of action and would otherwise not be identified through targeted screening approaches. Here, we discuss how zebrafish is an important model for drug discovery, the process of how these discoveries emerge and future opportunities for...Continue Reading

References

Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·R T PetersonS L Schreiber
Apr 21, 2004·Nature Biotechnology·Randall T PetersonMark C Fishman
Jun 22, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Lisa M J LeeMary J C Hendrix
Dec 24, 2005·Nature Chemical Biology·Howard M SternLeonard I Zon
Jan 13, 2006·Nature Chemical Biology·C Geoffrey BurnsMark C Fishman
Aug 8, 2006·Nature Medicine·Jolanta M TopczewskaMary J C Hendrix
Apr 6, 2007·Cancer Research·Stefania NicoliMarco Presta
May 19, 2007·Genes & Development·David M LangenauLeonard I Zon
Nov 21, 2007·Nature Chemical Biology·Paul B YuRandall T Peterson
Nov 26, 2008·Nature Medicine·Paul B YuKenneth D Bloch
Jan 28, 2009·Nature Chemical Biology·Jing-Ruey J YehRandall T Peterson
Oct 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Marta PerssonGöran Stenman
Mar 13, 2010·Science·Takumi ItoHiroshi Handa
Mar 27, 2010·Cancer Biology & Therapy·Igor V Mizgirev, Sergei Revskoy
Jun 23, 2010·Journal of the American Chemical Society·Vlado DancíkPaul A Clemons
Sep 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Trista E NorthWolfram Goessling
Mar 25, 2011·Nature·Richard Mark WhiteLeonard I Zon
Jun 28, 2011·Nature Reviews. Drug Discovery·David C Swinney, Jason Anthony
Dec 20, 2011·Nature Chemical Biology·Christian LaggnerBrian K Shoichet
Feb 22, 2012·PloS One·Veerander P S GhotraErik H J Danen
Mar 9, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Parhum NamdaranEdwin W Rubel
Jul 31, 2012·Chemistry & Biology·Linna ZhouE Elizabeth Patton
Sep 18, 2012·Developmental Biology·Maija K GarnaasWolfram Goessling
Dec 4, 2012·Nature Chemical Biology·Philipp GutDidier Y R Stainier
Apr 18, 2013·Zebrafish·Allan V KalueffUNKNOWN Zebrafish Neuroscience Research Consortium
Sep 5, 2013·Nature Communications·Scott C BarabanGabriela A Hortopan
Jan 16, 2014·Environmental Health Perspectives·Daniel A GorelickMarnie E Halpern

❮ Previous
Next ❯

Citations

Aug 28, 2021·International Journal of Molecular Sciences·Hoi-Khoanh GiongJeong-Soo Lee
Oct 2, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Aleksandr Shcheglovitov, Randall T Peterson
Nov 2, 2021·Frontiers in Molecular Neuroscience·Lise HeylenAleksandra Siekierska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Toxicological Sciences : an Official Journal of the Society of Toxicology
Katharine A Horzmann, Jennifer L Freeman
Advances in Experimental Medicine and Biology
Myron S IgnatiusDavid M Langenau
© 2021 Meta ULC. All rights reserved